Applied NeuroSolutions, Inc. (APNS) is a development stage
biopharmaceutical company engaged in the research and development of
products for the diagnosis and treatment of Alzheimer’s disease (AD).
Its core technology is based on exclusive licensing agreement with
Albert Einstein College of Medicine (AECOM), which covers all diagnostic
and therapeutic applications in the field of neurodegenerative disease.
The company strongly focuses on its research and development activities
to develop new products and launch in the market sooner. Currently,
APNS is working on both cerebrospinal fluid (CSF) based tests and serum
based tests to detect AD at an early stage. The company is headquartered
in Illinois, the US.
This comprehensive
SWOT profile of Applied
NeuroSolutions, Inc. provides you with an in-depth strategic analysis of
the company's businesses and operations. The profile will give you a
clear and an unbiased view of the company's key strengths and weaknesses
and the potential opportunities and threats. The profile helps you
formulate strategies that augment your business by enabling you to
understand your partners, customers and competitors better.
For more information kindly visit :
Applied NeuroSolutions, Inc.
No comments:
Post a Comment